Long-Acting Drug Delivery Technologies and Services Market to Grow with a CAGR of 10.34% through 2029F
Growing development of novel
technologies is expected to drive the Global Long-Acting Drug Delivery
Technologies and Services Market in the forecast period 2025-2029.
According to TechSci Research report, “Long-Acting
Drug Delivery Technologies and Services Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global
Long-Acting Drug Delivery Technologies and Services Market stood at
USD 10.23 billion in 2023 and is anticipated to grow with a CAGR of
10.34% in the forecast period through 2029. The Global Long-Acting Drug Delivery
Technologies and Services Market is witnessing substantial growth, driven by
escalating demand for extended-release formulations and enhanced patient
adherence. This market encompasses a diverse array of technologies and services
crafted to extend drug release, thereby amplifying therapeutic effectiveness
and diminishing dosing frequency. Long-acting drug delivery methods, including
injectable depots, implants, microparticles, and transdermal patches, offer sustained
release over prolonged periods, addressing limitations seen in conventional
dosage forms, especially in the management of chronic diseases.
Browse over XX market data
Figures spread through XX Pages and an in-depth TOC on "Global Long-Acting Drug Delivery Technologies and Services
Market”
The Global Long-Acting Drug Delivery Technologies
and Services Market is segmented into technique, dosage form, material used,
distribution channel, regional distribution, and company.
Based on Dosage Forms, the Long-acting Implantable segment is forecasted to
emerge as the dominant force. This projection stems from a myriad of factors
that collectively underscore the appeal and efficacy of implantable devices in
the global market. The escalating preference for sustained-release drug
delivery systems epitomizes a paradigm shift towards treatments that offer
enduring therapeutic benefits while enhancing patient adherence. Long-acting
implantable devices epitomize this ethos by providing a controlled and
sustained release of medications over an extended duration, thus obviating the
need for frequent dosing and streamlining treatment regimens for patients. Advancements in implantable technologies,
including the utilization of biodegradable polymers and the development of
miniaturized devices, have bolstered the segment's growth trajectory. These
innovations not only facilitate precise drug delivery but also mitigate
procedural invasiveness, thereby enhancing patient comfort and acceptance. The
burgeoning prevalence of chronic diseases, coupled with the ever-increasing
demand for more effective and convenient treatment modalities, further
amplifies the allure of long-acting implantable solutions. By offering a potent
combination of sustained efficacy, improved patient compliance, and procedural
convenience, the Long-acting Implantable segment is poised to address unmet
medical needs and propel innovation in the realm of long-term drug delivery
solutions, thus solidifying its position as a frontrunner in the global market.
Based on Material Used, the Polymer-based segment
is anticipated to dominate the Global Long-Acting Drug Delivery Technologies
and Services Market. Polymer-based materials offer several advantages that
align with the evolving needs of the pharmaceutical industry and healthcare
providers. Polymer-based long-acting drug delivery systems provide a versatile
platform for controlled release of medications over extended periods, ensuring
sustained therapeutic effects and improved patient compliance. These materials
can be engineered to achieve precise release kinetics, allowing for tailored
drug delivery profiles to meet specific therapeutic requirements. Polymer-based matrices offer excellent biocompatibility and biodegradability,
minimizing the risk of adverse reactions and facilitating safe and predictable
drug release. Polymer-based drug delivery systems
enable the incorporation of a wide range of therapeutic agents, including small
molecules, biologics, and nucleic acids, making them suitable for diverse
therapeutic applications. Their flexibility in formulation and manufacturing
processes allows for scalability and cost-effectiveness, essential factors in
the commercialization and widespread adoption of long-acting drug delivery
technologies.
Favorable regulatory frameworks and reimbursement
policies in North America facilitate the commercialization and adoption of
long-acting drug delivery technologies. Regulatory agencies such as the Food
and Drug Administration (FDA) in the United States prioritize patient safety
while fostering innovation, providing a conducive environment for the
development and approval of novel drug delivery systems. North
America's leadership in healthcare technology and digital health solutions
complements the development of long-acting drug delivery technologies, enabling
seamless integration with electronic health records, telemedicine platforms,
and other digital healthcare infrastructure. North America benefits from a large and affluent
population with high healthcare expenditure, creating a substantial market
demand for long-acting drug delivery technologies and services. The region's
aging population and rising prevalence of chronic diseases further drive the
need for innovative treatment modalities that offer improved efficacy, safety,
and patient convenience.
Major companies operating in
Global Long-Acting Drug Delivery Technologies and Services Market are:
- Adare Pharma Solutions
- Alkermes plc
- Camurus AB
- Corium, LLC.
- Creative Biolabs, Inc.
- Delpor, Inc.
- Durect Corporation
- Hanmi Pharm.Co.,Ltd.
- Integrated Bio Systems, Inc.
- Heron Therapeutics, Inc.
Download Free Sample Report
Customers can also request for
10% free customization on this report
“The Global Long-Acting Drug Delivery Technologies
and Services Market is driven by the rising demand for extended-release
formulations, coupled with innovations in biodegradable polymers and
nanotechnology, fuels market growth. The COVID-19 pandemic has
accelerated research, emphasizing the importance of sustained drug delivery in
critical care scenarios. These factors collectively propel the market,
fostering a patient-centric approach and necessitating inventive solutions for
prolonged drug administration”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“Long-Acting Drug Delivery Technologies and Services Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Injectables, Hydrogels, Implants, Microneedles, Nanocrystal Suspensions), By Dosage Forms (Long-acting Injectables, Long-acting Implantable, Topical / Transdermal, Vaginal, Other), By Material Used (Polymer based, Non-polymer based), By Distribution Channels (Hospitals and Retail Pharmacies, Research and Academics, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of
Global Long-Acting Drug Delivery Technologies and Services Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Long-Acting Drug Delivery Technologies
and Services Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com